Opioids: Difference between revisions
>Pjb m Cleaned up a bit from my last edit. Spelling and formatting. |
>Blackhole fixed wikipedia link |
||
(48 intermediate revisions by 19 users not shown) | |||
Line 3: | Line 3: | ||
[[File:Slaapbol R0017601.JPG|250px|thumb|Poppy pod scored to release opium latex]] | [[File:Slaapbol R0017601.JPG|250px|thumb|Poppy pod scored to release opium latex]] | ||
[[File:Mohn z06.jpg|250px|thumb|Dried pods for preparation of tea or solvent extraction of alkaloids]] | [[File:Mohn z06.jpg|250px|thumb|Dried pods for preparation of tea or solvent extraction of alkaloids]] | ||
'''Opioids''' are a class of [[psychoactive substances]] that resemble [[morphine]] or other opiates in their pharmacological effects.{{citation needed}} Opioids work by binding to opioid [[receptors]], which are found in the central and peripheral nervous system and the gastrointestinal tract.{{citation needed}} The receptors in these organ systems mediate both the beneficial effects and the side effects of opioids. | |||
Although the term opiate is often used as a synonym for opioid, the term opiate is limited to drugs derived from the natural alkaloids found in the resin of the opium poppy (''Papaver somniferum'')<ref>{{Cite book|url=https://books.google.com/books?id=s8CXrbimviMC&pg=PA268|title=Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application: Expert Consult - Online and Print|last=Hemmings|first=Hugh C.|last2=Egan|first2=Talmage D.|publisher=Elsevier Health Scienc,es|year=2013|isbn=1437716792|page=253 | Although the term opiate is often used as a synonym for opioid, the term opiate is limited to drugs derived from the natural alkaloids found in the resin of the opium poppy (''Papaver somniferum'').<ref>{{Cite book|url=https://books.google.com/books?id=s8CXrbimviMC&pg=PA268|title=Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application: Expert Consult - Online and Print|last=Hemmings|first=Hugh C.|last2=Egan|first2=Talmage D.|publisher=Elsevier Health Scienc,es|year=2013|isbn=1437716792|page=253|quote=Opiate is the older term classically used in pharmacology to mean a drug derived from opium. Opioid, a more modern term, is used to designate all substances, both natural and synthetic, that bind to opioid receptors (including antagonists).}}</ref> | ||
While opioid is a more general term for substances that act primarily on opioid receptors, including natural occurring alkaloids, synthetic substances and opioid peptides.<ref name=":17">{{Cite book|url=https://books.google.com/books?id=s8CXrbimviMC&pg=PA268|title=Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application: Expert Consult - Online and Print|last=Hemmings|first=Hugh C.|last2=Egan|first2=Talmage D.|publisher=Elsevier Health Sciences|year=2013|isbn=1437716792|page=253|quote=Opiate is the older term classically used in pharmacology to mean a drug derived from opium. Opioid, a more modern term, is used to designate all substances, both natural and synthetic, that bind to opioid receptors (including antagonists).}}</ref> | |||
Opioid dependence can develop with ongoing administration, leading to a withdrawal syndrome with abrupt discontinuation.<ref>Cammarano, W. B., Pittet, J. F., Weitz, S., Schlobohm, R. M., | Opioid dependence can develop with ongoing administration, leading to a withdrawal syndrome with abrupt discontinuation.<ref>{{cite journal | vauthors=((Cammarano, W. B.)), ((Pittet, J.-F.)), ((Weitz, S.)), ((Schlobohm, R. M.)), ((Marks, J. D.)) | journal=Critical Care Medicine | title=Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients: | volume=26 | issue=4 | pages=676–684 | date= April 1998 | url=http://journals.lww.com/00003246-199804000-00015 | issn=0090-3493 | doi=10.1097/00003246-199804000-00015}}</ref> Opioids are not only well known for their addictive properties, but also for their ability to produce a feeling of euphoria, motivating some to use opioids recreationally. | ||
==Chemistry== | ==Chemistry== | ||
Opioids are based upon [[morphine]] and opium-like structures. They work via their similar chemical structures to the endogenous opioids in the body. Morphine derived opioids, known as morphinans, contain a benzene ring attached to two partially unsaturated cyclohexane rings (phenanthrene) and a 4th nitrogenous ring attached to the core at carbons 9 and 13. There are several classes of opioids which differ greatly in structure from each other. For example, [[fentanyl]] and its analogues are structurally unique from [[morphinans]] and [[tramadol]] | Opioids are based upon [[morphine]] and opium-like structures. They work via their similar chemical structures to the endogenous opioids in the body. Morphine derived opioids, known as morphinans, contain a benzene ring attached to two partially unsaturated cyclohexane rings (phenanthrene) and a 4th nitrogenous ring attached to the core at carbons 9 and 13. There are several classes of opioids which differ greatly in structure from each other. For example, [[fentanyl]] and its analogues are structurally unique from [[morphinans]] and [[tramadol]] derivatives. | ||
==Pharmacology== | ==Pharmacology== | ||
[[File:Opioid_metabolism.png|thumb|Metabolic pathway of [[codeine]] and [[morphine]] courtesy of [https://www.pharmgkb.org/pathway/PA146123006 Pharmgkb.org] ]] | [[File:Opioid_metabolism.png|thumb|Metabolic pathway of [[codeine]] and [[morphine]] courtesy of [https://www.pharmgkb.org/pathway/PA146123006 Pharmgkb.org] ]] | ||
Opioids are known to mimic endogenous endorphins. Endorphins are responsible for analgesia (reducing pain), causing sleepiness, and feelings of pleasure. They can be released in response to pain, strenuous exercise, orgasm, or excitement. | Opioids are known to mimic endogenous endorphins. Endorphins are responsible for analgesia (reducing pain), causing sleepiness, and feelings of pleasure. They can be released in response to pain, strenuous exercise, orgasm, or excitement. This mimicking of natural endorphins results in the drug's [[Physical euphoria|euphoric]], [[Pain relief|analgesic]] (pain relief) and [[Anxiety suppression|anxiolytic]] (anti-anxiety) effects.<ref>{{cite journal | vauthors = Boecker H, Sprenger T, Spilker ME, Henriksen G, Koppenhoefer M, Wagner KJ, Valet M, Berthele A, Tolle TR | title = The runner's high: opioidergic mechanisms in the human brain | journal = Cerebral Cortex | volume = 18 | issue = 11 | pages = 2523–31 | date = November 2008 | pmid = 18296435 | doi = 10.1093/cercor/bhn013 }}</ref> | ||
===Receptor types=== | ===Receptor types=== | ||
Opioids act on the three main classes of | Opioids act on the three main classes of opioid receptor in the nervous system, μ, κ, δ (mu, kappa, and delta).<ref name="receptors">Opioid - Chapter 2: The Endogeneous Opioid Systems | ||
(http://www.stoppain.org / Beth Israel Medical Center's Department of Pain Medicine and Palliative Care) | https://web.archive.org/web/20110719072413/http://www.stoppain.org/pcd/_pdf/OpioidChapter2.pdf</ref> Each opioid is measured by its [[agonist]]ic or [[antagonist]]ic effects towards the receptors, with the responses to the different receptor sub-types (e.g., μ1 and μ2) providing even more effects. Opioid receptors are found mainly within the brain, but also within the spinal cord and digestive tract.<ref>{{cite journal | vauthors=((Holzer, P.)) | journal=Regulatory peptides | title=Opioid receptors in the gastrointestinal tract | volume=155 | issue=1–3 | pages=11–17 | date=5 June 2009 | url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163293/ | issn=0167-0115 | doi=10.1016/j.regpep.2009.03.012}}</ref> | |||
====='''Delta (δ)'''===== | ====='''Delta (δ)'''===== | ||
The delta receptor is responsible for the [[analgesia]], antidepressant and convulsant effects as well as physical dependence. | The delta receptor is responsible for the [[analgesia]], antidepressant and convulsant effects as well as physical dependence.<ref name="receptors" /> | ||
====='''Kappa (κ)'''===== | ====='''Kappa (κ)'''===== | ||
The kappa receptor is responsible for the [[analgesia]], [[anticonvulsant]], [[dissociative]] and [[deliriant]] effects as well as dysphoria, neuroprotection and [[sedation]]. | The kappa receptor is responsible for the [[analgesia]], [[anticonvulsant]], [[dissociative]] and [[deliriant]] effects as well as dysphoria, neuroprotection and [[sedation]].<ref name="receptors" /> | ||
====='''Mu (μ)'''===== | ====='''Mu (μ)'''===== | ||
The mu receptor is responsible for [[analgesia]], physical dependence, [[respiratory depression]], [[euphoria]], and possible [[vasodilation]]. | The mu receptor is responsible for [[analgesia]], physical dependence, [[respiratory depression]], [[euphoria]], and possible [[vasodilation]].<ref name="receptors" /> | ||
Agonists of mu opioid receptors produce sedative, euphoric, and anxiolytic effects largely through the interaction of the mu receptors with serotonin, dopamine, and norepinephrine. Activation of mu receptors allows for the disinhibition of serotonin and dopamine neurons by blocking the inhibitory effects of GABA on serotonin and dopamine neurons, thus increasing activity and release of serotonin and dopamine.<ref>https://www.sciencedirect.com/science/article/abs/pii/S1043661818306145</ref> Mu receptors additionally inhibit the activity of norepinephrine neurons, leading to sedation, anxiolysis, and respiratory depression.<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274960/</ref> | |||
====='''Nociceptin'''===== | ====='''Nociceptin'''===== | ||
The nociceptin receptor is responsible for [[anxiety]], [[depression]], appetite and development of tolerance to μ agonists.{{ | The nociceptin receptor is responsible for [[anxiety]], [[depression]], appetite and development of tolerance to μ agonists.<ref name="pmid10742280">{{cite journal | vauthors = Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D | title = Pharmacology of nociceptin and its receptor: a novel therapeutic target | journal = British Journal of Pharmacology | volume = 129 | issue = 7 | pages = 1261–83 | date = April 2000 | pmid = 10742280 | pmc = 1571975 | doi = 10.1038/sj.bjp.0703219 }}</ref><ref>{{cite journal | vauthors = Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT | title = Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems | journal = Pharmacological Reviews | volume = 68 | issue = 2 | pages = 419–57 | date = April 2016 | pmid = 26956246 | doi = 10.1124/pr.114.009209 | url = http://pharmrev.aspetjournals.org/content/68/2/419 }}</ref> | ||
=====''' | |||
The | ====='''Zeta (ζ)'''===== | ||
The zeta opioid receptor, also known as opioid growth factor receptor (OGFr) is responsible for tissue growth, neural development, and is further implicated in the development in some cancers.<ref name="pmid10519055">{{cite journal | vauthors = Zagon IS, Wu Y, McLaughlin PJ | title = Opioid growth factor and organ development in rat and human embryos | journal = Brain Res. | volume = 839 | issue = 2 | pages = 313–22 |date=August 1999 | pmid = 10519055 | doi = 10.1016/S0006-8993(99)01753-9 | url = | issn = }}</ref><ref name="pmid12854052">{{cite journal | vauthors = Sassani JW, Zagon IS, McLaughlin PJ | title = Opioid growth factor modulation of corneal epithelium: uppers and downers | journal = Curr. Eye Res. | volume = 26 | issue = 5 | pages = 249–62 |date=May 2003 | pmid = 12854052 | doi = 10.1076/ceyr.26.4.249.15427| url = | issn = }}</ref><ref name="pmid10024694">{{cite journal | vauthors = Zagon IS, Smith JP, McLaughlin PJ | title = Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor | journal = Int. J. Oncol. | volume = 14 | issue = 3 | pages = 577–84 |date=March 1999 | pmid = 10024694 | doi = 10.3892/ijo.14.3.577| url = | issn = }}</ref><ref name="pmid10200353">{{cite journal | vauthors = McLaughlin PJ, Levin RJ, Zagon IS | title = Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor | journal = Int. J. Oncol. | volume = 14 | issue = 5 | pages = 991–8 |date=May 1999 | pmid = 10200353 | doi = 10.3892/ijo.14.5.991| url = | issn = }}</ref><ref name="pmid17974995">{{cite journal |vauthors=Cheng F, Zagon IS, Verderame MF, McLaughlin PJ |title=The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer |journal=Cancer Research |volume=67 |issue=21 |pages=10511–8 |date=November 2007 |pmid=17974995 |doi=10.1158/0008-5472.CAN-07-1922 |url= |issn=}}</ref><ref name="pmid19297547">{{cite journal |vauthors=Donahue RN, McLaughlin PJ, Zagon IS |title=Cell Proliferation of Human Ovarian Cancer is Regulated by the Opioid Growth Factor - Opioid Growth Factor Receptor Axis |journal=American Journal of Physiology. Regulatory, Integrative and Comparative Physiology |volume= 296|issue= 6|pages= R1716–25|date=March 2009 |pmid=19297547 |doi=10.1152/ajpregu.00075.2009 |url= |issn=}}</ref> The endogenous ligand for OGFr is met-enkephalin, which is also a powerful endogenous delta opioid receptor agonist.<ref name="Stein1999">{{cite book | author = Christoph Stein | title = Opioids in pain control: basic and clinical aspects | url = https://books.google.com/books?id=4Rfr8cQayvgC&pg=PA22 | accessdate = 25 November 2011 | year = 1999 | publisher = Cambridge University Press | isbn = 978-0-521-62269-1 | pages = 22–23}}</ref> | |||
==Subjective effects== | ==Subjective effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
{{effects/base | |||
|{{effects/physical| | |||
*'''[[Stimulation]] or [[Sedation]]''' - At light doses, mu opioid agonists often produce mild to moderate stimulation due to enhancing dopamine and serotonin signaling, which gradually changes to sedation with higher doses due to inhibition of norepinephrine. Opioids with stronger activity at kappa and nociceptin opioid receptors such as [[fentanyl]] and [[morphine]] tend to be more sedating than opioids which primarily act on mu opioid receptors like [[kratom]] and [[tianeptine]] | |||
*'''[[Respiratory depression|Respiratory depression]]''' - At low to moderate doses, this effect results in the sensation that the breath is slowed down mildly to moderately, but does not cause noticeable impairment. At high doses and overdoses, opioid-induced respiratory depression can result in a shortness of breath, abnormal breathing patterns, semi-consciousness, or unconsciousness. Severe overdoses can result in a coma or death without immediate medical attention. | *'''[[Respiratory depression|Respiratory depression]]''' - At low to moderate doses, this effect results in the sensation that the breath is slowed down mildly to moderately, but does not cause noticeable impairment. At high doses and overdoses, opioid-induced respiratory depression can result in a shortness of breath, abnormal breathing patterns, semi-consciousness, or unconsciousness. Severe overdoses can result in a coma or death without immediate medical attention. | ||
*'''[[ | *'''[[Pain relief]]''' | ||
*'''[[ | *'''[[Itchiness]]''' | ||
*'''[[ | *'''[[Constipation]]''' | ||
*'''[[ | *'''[[Cough suppression]]''' | ||
*'''[[ | *'''[[Decreased libido]]''' | ||
*'''[[ | *'''[[Difficulty urinating]]''' | ||
*'''[[ | *'''[[Nausea]]''' | ||
*'''[[Stomach cramps | *'''[[Stomach cramps]]''' | ||
*'''[[Pupil constriction]]''' | |||
*'''[[ | |||
*'''[[Orgasm suppression]]''' | *'''[[Orgasm suppression]]''' | ||
}} | |||
|{{effects/cognitive| | |||
*'''[[Cognitive euphoria]]''' - This can be described as a powerful and overwhelming feeling of emotional bliss, contentment, and happiness. | |||
*'''[[Motivation enhancement]]''' - Some opioids (such as [[kratom]]) are more stimulating than others and seem to enhance motivation. | |||
*'''[[Anxiety suppression]]''' | |||
*'''[[Cognitive euphoria | |||
*'''[[ | |||
*'''[[ | |||
*'''[[Compulsive redosing]]''' | *'''[[Compulsive redosing]]''' | ||
*'''[[Dream potentiation]]''' | *'''[[Dream potentiation]]''' | ||
*'''[[Increased music appreciation]]''' | |||
}} | |||
{{effects/visual| | |||
====Suppressions==== | |||
*'''[[Effect::Double vision]]''' - At high doses, opioids can cause the eyes un-focus and re-focus uncontrollably. This creates a blurred effect and double vision that is present no matter where one focuses their eyes. | |||
====Hallucinatory states==== | |||
*'''[[Internal hallucinations]]''' - One may experience feelings of hypnagogia during a state of "nodding" which is often accompanied by vivid dream-like visions. | *'''[[Internal hallucinations]]''' - One may experience feelings of hypnagogia during a state of "nodding" which is often accompanied by vivid dream-like visions. | ||
}} | |||
}} | |||
== | ==Chemical classes== | ||
<div class= | <div class="flex-panel"> | ||
<div class= | <div class="flex-column"> | ||
<div class="panel radius"> | <div class="panel radius"> | ||
<h3 class="panel-header">Naturally occuring[[file:leaf.svg|20px|right]]</h3> | <h3 class="panel-header">Naturally occuring[[file:leaf.svg|20px|right]]</h3> | ||
Line 94: | Line 80: | ||
<ul class="featured-table"> | <ul class="featured-table"> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
*'''[[Morphine]]''' | *'''[[Morphine]]''' | ||
*'''[[Codeine]]''' | *'''[[Codeine]]''' | ||
*'''[[Kratom]]''' | *'''[[Kratom]]''' | ||
*'''Poppy''' | |||
*'''Corydalis''' | |||
*'''Glaucium''' | |||
*'''Sophora''' | |||
*'''Rotundine''' | |||
*'''Glaucine''' | |||
*'''Matrine''' | |||
</li> | </li> | ||
</ul> | </ul> | ||
Line 106: | Line 101: | ||
<ul class="featured-table"> | <ul class="featured-table"> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
*'''[[Buprenorphine]]''' (Subutex, Suboxone) | |||
*'''[[Diacetylmorphine]]''' (Heroin) | *'''[[Diacetylmorphine]]''' (Heroin) | ||
*'''[[Dihydrocodeine]]''' | |||
*'''[[Desomorphine]]''' | |||
*'''[[Ethylmorphine]]''' | *'''[[Ethylmorphine]]''' | ||
*'''[[Hydrocodone]]''' | *'''[[Hydrocodone]]''' | ||
*'''[[Hydromorphone]]''' | *'''[[Hydromorphone]]''' | ||
*'''[[Oxycodone]]''' | *'''[[Oxycodone]]''' | ||
*'''[[Oxymorphone]]''' | *'''[[Oxymorphone]]''' | ||
*'''[[Naloxone]]''' (Narcan) - This is a powerful antagonist which precipitates instant withdrawal and is used to recover from overdose. | *'''[[Naloxone]]''' (Narcan) - This is a powerful antagonist which precipitates instant withdrawal and is used to recover from overdose. | ||
</li> | </li> | ||
Line 120: | Line 116: | ||
</div> | </div> | ||
<div class= | <div class="flex-column"> | ||
<div class="panel radius"> | <div class="panel radius"> | ||
<h3 class="panel-header">Synthetic[[file:flask.svg|20px|right]]</h3> | <h3 class="panel-header">Synthetic[[file:flask.svg|20px|right]]</h3> | ||
Line 128: | Line 124: | ||
*'''[[Acetylfentanyl]]''' | *'''[[Acetylfentanyl]]''' | ||
*'''[[Dextropropoxyphene]]''' | *'''[[Dextropropoxyphene]]''' | ||
*[[Diacetyldihydromorphine]] | |||
*'''[[Fentanyl]]''' | *'''[[Fentanyl]]''' | ||
*'''[[Sufentanil]]''' | *'''[[Sufentanil]]''' | ||
Line 133: | Line 130: | ||
*'''[[Tapentadol]]''' | *'''[[Tapentadol]]''' | ||
*'''[[Tramadol]]''' | *'''[[Tramadol]]''' | ||
*'''[[Tianeptine]]''' | |||
*'''[[Tilidine]]''' | |||
*'''[[Pethidine]]''' (Meperidine) | *'''[[Pethidine]]''' (Meperidine) | ||
*'''[[O-Desmethyltramadol]]''' | *'''[[O-Desmethyltramadol]]''' | ||
Line 140: | Line 139: | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="panel radius"> | |||
<h3 class="panel-header">Nitazenes[[file:cubes.svg|20px|right]]</h3> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
*[[α-carboxamido-clonitazene]] | |||
*[[α-methyl-metonitazene]] | |||
*[[Acetoxynitazene]] | |||
*[[Bronitazene]] | |||
*[[Butonitazene]] | |||
*[[Clonitazene]] | |||
*[[Dimetonitazene]] | |||
*[[Ethylnitazene]] | |||
*[[Ethylthionitazene]] | |||
*[[Etodesnitazene ]] (Etazene) | |||
*[[Etoetonitazene]] | |||
*[[Etonitazene]] | |||
*[[Etonitazepipne]] | |||
*[[Etonitazepyne]] | |||
*[[Fluonitazene]] | |||
*[[Isotonitazene]] | |||
*[[Methylnitazene]] | |||
*[[Methylthionitazene]] | |||
*[[Metodesnitazene]] (Metazene) | |||
*[[meta-Metonitazene]] | |||
*[[Metonitazene]] | |||
*[[N-desethyl-isotonitazene]] | |||
*[[Nitazene]] | |||
*[[O-Desmethyl-etonitazene]] | |||
*[[Propylnitazene]] | |||
*[[Protodesnitazene]] | |||
*[[Protonitazene]] | |||
*[[t-Butylnitazene]] | |||
</li> | |||
</ul> | |||
</div> | |||
</div> | </div> | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
{{toxicity}} | |||
The short-term non-chronic use of opioids is not associated with any physical or neurological toxicity.{{citation needed}} | |||
===Long term effects=== | ===Long term effects=== | ||
The long-term use of opioids causes hormonal imbalance in both men and women.<ref>{{cite journal | vauthors=((Brennan, M. J.)) | journal=The American Journal of Medicine | title=The effect of opioid therapy on endocrine function | volume=126 | issue=3 Suppl 1 | pages=S12-18 | date= March 2013 | issn=1555-7162 | doi=10.1016/j.amjmed.2012.12.001}}</ref> In men, this opioid-induced androgen deficiency results in abnormally low levels of sex hormones, particularly testosterone.<ref>{{cite journal | vauthors=((Smith, H. S.)), ((Elliott, J. A.)) | journal=Pain Physician | title=Opioid-induced androgen deficiency (OPIAD) | volume=15 | issue=3 Suppl | pages=ES145-156 | date= July 2012 | issn=2150-1149}}</ref> | |||
This negative change in endocrine function in males can lead to: reduced libido, erectile dysfunction, fatigue, depression, reduced facial and body hair, decreased muscle mass, and weight gain. | |||
This | Another often observed long-term effect is hyperalgesia, an increase in the pain sensitivity of the person. This is specially seen in chronic pain patients on high dose opioid regimes. There is some evidence that NMDA antagonists like [[ketamine]] and opoids that are also weak NMDA antagonist such as [[methadone]], [[levorphanol]] and [[tramadol]] may help delay the onset of hyperalgesia or even revert it.<ref>{{cite journal | vauthors=((Lee, M.)), ((Silverman, S. M.)), ((Hansen, H.)), ((Patel, V. B.)), ((Manchikanti, L.)) | journal=Pain Physician | title=A comprehensive review of opioid-induced hyperalgesia | volume=14 | issue=2 | pages=145–161 | date= April 2011 | issn=2150-1149}}</ref> | ||
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this class of substances. | |||
===Tolerance and addiction potential=== | ===Tolerance and addiction potential=== | ||
Due to the highly euphoric nature of these substances, the recreational use and abuse of opioids has an extremely high rate of addiction and dependence. This is combined with a tolerance which builds up quickly, necessitates that the user take increasingly high dosages in order to get the same effects. | Due to the highly euphoric nature of these substances, the recreational use and abuse of opioids has an extremely high rate of addiction and dependence. This is combined with a tolerance which builds up quickly, necessitates that the user take increasingly high dosages in order to get the same effects. | ||
The risk of fatal opioid overdoses rise sharply after a period of cessation and [[relapse]], largely because of reduced tolerance.<ref>Why Heroin Relapse Often Ends In Death - Lauren F Friedman (Business Insider) | http://www.businessinsider.com.au/philip-seymour-hoffman-overdose-2014-2</ref> To account for this lack of tolerance, it is safer to only dose a fraction of one's usual [[dosage]] if relapsing. It has also been found that the environment one is in can play a role in opioid tolerance. In one scientific study, rats with the same history of heroin administration were significantly more likely to die after receiving their dose in an environment not associated with the drug in contrast to a familiar environment.<ref>Siegel, S., Hinson, R., Krank, M., | The risk of fatal opioid overdoses rise sharply after a period of cessation and [[relapse]], largely because of reduced tolerance.<ref>Why Heroin Relapse Often Ends In Death - Lauren F Friedman (Business Insider) | http://www.businessinsider.com.au/philip-seymour-hoffman-overdose-2014-2</ref> To account for this lack of tolerance, it is safer to only dose a fraction of one's usual [[dosage]] if relapsing. It has also been found that the environment one is in can play a role in opioid tolerance. In one scientific study, rats with the same history of heroin administration were significantly more likely to die after receiving their dose in an environment not associated with the drug in contrast to a familiar environment.<ref>{{cite journal | vauthors=((Siegel, S.)), ((Hinson, R. E.)), ((Krank, M. D.)), ((McCully, J.)) | journal=Science | title=Heroin “Overdose” Death: Contribution of Drug-Associated Environmental Cues | volume=216 | issue=4544 | pages=436–437 | date=23 April 1982 | url=https://www.science.org/doi/10.1126/science.7200260 | issn=0036-8075 | doi=10.1126/science.7200260}}</ref> | ||
===Dangerous interactions=== | |||
{{DangerousInteractions/Intro}} | |||
{{DangerousInteractions/Opioids}} | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[ | *[[Depressant]] | ||
*[[Kratom]] | *[[Kratom]] | ||
*[[Codeine]] | *[[Codeine]] | ||
Line 175: | Line 210: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Opioid Opioid (Wikipedia)] | *[https://en.wikipedia.org/wiki/Opioid Opioid (Wikipedia)] | ||
*[https://erowid.org/chemicals/opiates/opiates.shtml Opiates (Erowid Vault)] | *[https://erowid.org/chemicals/opiates/opiates.shtml Opiates (Erowid Vault)] | ||
*[https://en.wikipedia.org/wiki/List_of_benzimidazole_opioids List of benzimidazole opioids (Wikipedia)] | |||
==References== | ==References== | ||
{{ | <references /> | ||
[[Category:Anaphrodisiac]] | |||
[[Category:Psychoactive class]] | |||
[[Category:Opioid| ]] | |||
[[Category:Pharmacology]] | |||
{{#set:Featured=true}} |